Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Alsharqi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Dermatology|October 19, 2011
A linear rash: a clinicopathological challenge. What is your diagnosis?Ali Alsharqi, Richard Parslew
The Australasian Journal of Dermatology|December 2, 2025
Successful Use of Dupilumab in the Management of Recalcitrant Pemphigoid GestationisStephanie-Lynn Ryan, Ali Alsharqi
Clinical and Experimental Dermatology|February 6, 2023
Switching from adalimumab originator to biosimilar: a 3-year retrospective cohort analysisLisa Killion, Ali Alsharqi, Brian Kirby
The Australasian Journal of Dermatology|June 16, 2010
Eczema occurring after cutaneous injuryAli Alsharqi, Clodagh King, Kath Panting
The Australasian Journal of Dermatology|May 11, 2012
Craniofacial hyperhidrosis in post-menopausal womenAli Alsharqi, Niall J E Wilson
Dermatology Online Journal|September 30, 2010
A 3-month-old with a blistering plaqueAli Alsharqi, Richard Parslew, Rajeev Shukla
The Australasian Journal of Dermatology|May 11, 2012
Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?Ali Alsharqi, Richard Parslew, Bernadette Dever, et al.
Clinical and Experimental Dermatology|June 30, 2025
An observation of weight gain in patients with atopic dermatitis receiving dupilumabDarren Roche, Donal O'Shea, Brian Kirby, et al.
Pediatric Dermatology|January 31, 2017
Use of Phototherapy in ChildrenKaren Eustace, Sophie Dolman, Ali Alsharqi, et al.
The Australasian Journal of Dermatology|October 13, 2016
Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapyNekma Meah, Ali Alsharqi, Richard M Azurdia, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Dermatology|October 19, 2011
A linear rash: a clinicopathological challenge. What is your diagnosis?Ali Alsharqi, Richard Parslew
The Australasian Journal of Dermatology|December 2, 2025
Successful Use of Dupilumab in the Management of Recalcitrant Pemphigoid GestationisStephanie-Lynn Ryan, Ali Alsharqi
Clinical and Experimental Dermatology|February 6, 2023
Switching from adalimumab originator to biosimilar: a 3-year retrospective cohort analysisLisa Killion, Ali Alsharqi, Brian Kirby
The Australasian Journal of Dermatology|June 16, 2010
Eczema occurring after cutaneous injuryAli Alsharqi, Clodagh King, Kath Panting
The Australasian Journal of Dermatology|May 11, 2012
Craniofacial hyperhidrosis in post-menopausal womenAli Alsharqi, Niall J E Wilson
Dermatology Online Journal|September 30, 2010
A 3-month-old with a blistering plaqueAli Alsharqi, Richard Parslew, Rajeev Shukla
The Australasian Journal of Dermatology|May 11, 2012
Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?Ali Alsharqi, Richard Parslew, Bernadette Dever, et al.
Clinical and Experimental Dermatology|June 30, 2025
An observation of weight gain in patients with atopic dermatitis receiving dupilumabDarren Roche, Donal O'Shea, Brian Kirby, et al.
Pediatric Dermatology|January 31, 2017
Use of Phototherapy in ChildrenKaren Eustace, Sophie Dolman, Ali Alsharqi, et al.
The Australasian Journal of Dermatology|October 13, 2016
Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapyNekma Meah, Ali Alsharqi, Richard M Azurdia, et al.
Pageof 2